COACH-ED Expert Meeting in Berlin 2025
Crosstalks on Diagnosing and Managing Cancer Cachexia
Join us in shaping the future standard of care for cancer cachexia
COACH-ED Meeting in Berlin is over. Stay tuned for more information about our upcoming online educational program
COACH-ED Expert Meeting in Berlin 2025
Crosstalks on Diagnosing and Managing Cancer Cachexia
Join us in shaping the future standard of care for cancer cachexia
Two expert-led sessions will take place on:
DATE & TIME
17 October, 2025
19:30 – 21:30 CEST
19 October, 2025
19:30 – 21:30 CEST
Location
Campus Charité Mitte, Museum of Medical History, Berlin
COACH-ED – the Collaborative Oncology Alliance for CacHexia Education, is a long-term global initiative to enhance the clinical recognition and management of cancer cachexia (CC).
Led by the Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD) and the Cancer Cachexia Society (CCS), in collaboration with local host in Berlin the Charité Trust, COACH-ED is designed to create a scientific dialogue and build a sustained international network of expert medical oncologists dedicated to better outcomes for patients living with this often-overlooked syndrome.
Why This Matters
Who Should Attend?
Medical oncologists interested in improving cachexia care and engaging in a growing global network focused on systemic change. Based on an international and multidisciplinary scientific dialogue, your participation will help shape future standards of cancer cachexia management across healthcare organizations.
Why Attend?
Improve patient outcomes: Share best practices to recognize and treat cancer cachexia earlier and more effectively.
Be part of something bigger: Help shape a pan-European network of cachexia-informed oncology leaders—a growing community that will drive better outcomes across the cancer care continuum.
Lead the change: The Berlin meetings mark the launch of a global movement to bring cachexia to the forefront of oncology care. Your participation matters.
About Cancer cachexia (CC)
CC is defined as a multifactorial syndrome of weight loss characterized by skeletal muscle loss (with or without loss of fat mass) found in the presence of underlying malignant disease (Fearon et al 2011).
Half of all cancer deaths worldwide are attributed to the cancers most frequently associated with cachexia, namely, pancreatic (0.33 million deaths), oesophageal (0.40 million), gastric (0.72 million), pulmonary (1.59 million), hepatic (0.75 million) and colorectal (0.69 million) cancers.
References
Arends J, Strasser F, Gonella S, Solheim TS, Madeddu C, Ravasco P, Buonaccorso L, de van der Schueren MAE, Baldwin C, Chasen M, Ripamonti CI; ESMO Guidelines Committee. ESMO Open. 2021 Jun;6(3):100092.
Roeland EJ, Bohlke K, Baracos VE, Smith TJ, Loprinzi CL; Cancer Cachexia Expert Panel. Cancer Cachexia: ASCO Guideline Rapid Recommendation Update. J Clin Oncol. 2023 Sep 1;41(25):4178-4179.
Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011 May;12(5):489-95.
Farkas J, von Haehling S, Kalantar-Zadeh K, Morley JE, Anker SD, Lainscak M. Cachexia as a major public health problem: frequent, costly, and deadly. J Cachexia Sarcopenia Muscle. 2013 Sep;4(3):173-8.
Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH. Cancer-associated cachexia. Nat Rev Dis Primers. 2018 Jan 18;4:17105.
Goncalves MD, Dunne RF, Moore AC, Phillips W, Heymsfield SB, Brown JC, Talbert EE, Janowitz T. Call to Improve Coding of Cancer-Associated Cachexia. JCO Oncol Pract. 2025 Jul;21(7):926-931.
17 October
19:30 - 21:30 CEST
Save on calendar
Stefan Anker
President – SCWD
University of Milan and European Institute of Oncology, IRCCS Milan
Richard Skipworth
CCS
Stefan Anker
SCWD
ESMO president-elect
Richard Skipworth
CCS
Lars Bullinger
Stefan Anker
SCWD
Giuseppe Curigliano
ESMO president-elect
Richard Skipworth
CCS
Charité
TBC
Charité medical school
Giuseppe Curigliano
ESMO president-elect
Jeffrey Crawford
19.55-20.05: Recognizing and Diagnosing Cancer Cachexia: What every oncologist should know
Maurizio Muscaritoli
20.05-20.15: Current non pharmaceutical therapies for cancer cachexia
Richard Skipworth
20.15-20.25: Pharmacological management of cancer cachexia, existing and emerging therapies
Karin Jordan
20.25-20.55: Interactive Case 1
Moderator:
Richard Skipworth
All participants
20.55-21.00: Closing and key take outs
Dinner at the Museum (with support of Charité Trust)
19 October
20:00 - 22:00 CEST
Save on calendar
20.00-20.15: Welcome & introductions by the chairs
Florian Strasser
SCWD
Tora Solheim
CCS
Jean-Yves Blay
ESMO director of public policy
Florian Strasser
SCWD
Tora Solheim
CCS
Jean-Yves Blay
ESMO director of public policy
Ulrich Keller
Charité
Florian Scotté
President – MASCC
Ulrich Keller
Charité
Florian Scotté
President – MASCC
Ulrich Keller
Charité
Tora Solheim
CCS
Jean Yves Blais
ESMO director of public policy
Ulrich Keller
Charité
Florian Scotté
President – MASCC
20.15-20.25: The Hidden Burden: Why cachexia matters
Alessandro Laviano
20.25-20.35: Recognizing and Diagnosing Cancer Cachexia: What every oncologist should know
Paula Ravasco
20.35-20.45: Current non pharmaceutical therapies for cancer cachexia
Tora Solheim
20.45-20.55: Pharmacological management of cancer cachexia, existing and emerging therapies
Jeffrey Crawford
20.55-21.25: Interactive Case 1
Moderator:
Florian Scotté
All participants
21.25-21.30: Closing and key take outs
21.30-22.00: Drinks reception
Dinner at the Museum (with support of Charité Trust)
Seats are limited - secure your spot today
Free registration (limited to 100 participants per session)
17 October
19:00 - 21:30 CEST
Save on calendar
Stefan Anker
SCWD
Maurizio Muscaritoli
SCWD
Richard Skipworth
CCS
Stefan Anker
SCWD
Maurizio Muscaritoli
SCWD
Richard Skipworth
CCS
TBC
Charité medical school
Giuseppe Curigliano
ESMO president-elect
TBC
Charité medical school
Giuseppe Curigliano
ESMO president-elect
The hidden burden: why cancer cachexia matters
Alessandro Laviano
Recognizing and Diagnosing Cancer Cachexia: What every oncologist should know
Jeff Crawford
Current non pharmaceutical therapies for cancer cachexia
Richard Skipworth
Pharmacological management of cancer cachexia, existing and emerging therapies
TBC
TBC
Panel discussion with ambassadors of the program
Dinner at the Museum (with support of Charité Trust)
19 October
19:30 - 21:30 CEST
Save on calendar
19:30: Welcome with finger foods
Stefan Anker
SCWD
Tora Solheim
CCS
Jean Yves Blais
ESMO director of public policy
Stefan Anker
SCWD
Tora Solheim
CCS
Jean Yves Blais
ESMO director of public policy
TBC
Charité medical school
TBC
Charité medical school
The hidden burden: why cancer cachexia matters
Alessandro Laviano
Recognizing and Diagnosing Cancer Cachexia: What every oncologist should know
Jeff Crawford
Current non pharmaceutical therapies for cancer cachexia
Richard Skipworth
Pharmacological management of cancer cachexia, existing and emerging therapies
TBC
TBC
Panel discussion with ambassadors of the program
Dinner at the Museum (with support of Charité Trust)
Seats are limited - secure your spot today
Free registration (limited to 100 participants per session)
Faculty and Scientific Committee
Faculty
Lars Bullinger
Jean-Yves Blay
France
USA
Karin Jordan
Ulrich Keller
Alessandro Laviano
Maurizio Muscaritoli
Italy
Paula Ravasco
Portugal
Richard Skipworth
UK
Norway
Florian Scotté
Florian Strasser
Switzerland
Lars Bullinger
Jean-Yves Blay
France
USA
Karin Jordan
Germany
Ulrich Keller
Alessandro Laviano
Maurizio Muscaritoli
Italy
Paula Ravasco
Portugal
Richard Skipworth
UK
Tora Solheim
Norway
Florian Scotté
Florian Strasser
Switzerland
Scientific committee
Stefan Anker
Germany
Vickie Baracos
Canada
Giuseppe Curigliano
Italy
Marcus D. Goncalves
USA
Egidio del Fabbro
USA
José Garcia
USA
Aminah Jatoi
USA
Andy Judge
UK
Japan
Barry Laird
UK
Paula Ravasco
Portugal
Eric Roeland
USA
Richard Skipworth
UK
Stefan Ankerr
Germany
Vickie Baracos
Canada
Giuseppe Curigliano
Italy
Marcus D. Goncalves
USA
Egidio del Fabbro
USA
José Garcia
USA
Aminah Jatoi
USA
Andy Judge
UK
Tateaki Naito
Japan
Barry Laird
UK
Paula Ravasco
Portugal
Eric Roeland
USA
Richard Skipworth
UK
